So far, available human data of intermittent fasting focusing specifically on people with type 2 diabetes mellitus treated with insulin, looking into potential glycaemic, body weight and treatment improvements, are mainly limited to case series.10, 11. The gene discussed is INS; the disease is diabetes mellitus.